Myomo (MYO) Cyclically Adjusted FCF per Share: $-13.53 (As of Mar. 2026)


MYO Myomo Inc MYO
57 GF Score
Price $1.10
GF Value $3.14
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Myomo Cyclically Adjusted FCF per Share?

Myomo MYO -5.17% 57 Cyclically Adjusted FCF per Share is $-13.53 as of Mar. 2026. GuruFocus rates MYO with a GF Score™ of 57/100 and a GF Value™ of $3.14 (Possible Value Trap). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Myomo's adjusted free cash flow per share for the three months ended in Mar. 2026 was $-0.064. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $-13.53 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2026-07-11), Myomo's current stock price is $1.10. Myomo's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was $-13.53. Myomo's Cyclically Adjusted Price-to-FCF of today is .


Myomo  (AMEX:MYO) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Myomo Cyclically Adjusted FCF per Share Related Terms


Myomo Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Myomo's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Myomo Cyclically Adjusted FCF per Share Chart

Myomo Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Myomo Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -13.53

MYO vs FOFA, ELUT, PAVM: Cyclically Adjusted FCF per Share Comparison

For the Medical Devices subindustry, Myomo's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Myomo Cyclically Adjusted Price-to-FCF vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Myomo's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Myomo's Cyclically Adjusted Price-to-FCF falls into.


MYO
57GF Score
Myomo Inc MYO
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Myomo Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Myomo's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-0.064/330.2130*330.2130
=-0.064

Current CPI (Mar. 2026) = 330.2130.

Myomo Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 0.000 241.018 0.000
201609 -6.140 241.428 -8.398
201612 -4.224 241.432 -5.777
201703 -5.449 243.801 -7.380
201706 -20.597 244.955 -27.766
201709 -9.192 246.819 -12.298
201712 -4.318 246.524 -5.784
201803 -5.869 249.554 -7.766
201806 -5.705 251.989 -7.476
201809 -6.085 252.439 -7.960
201812 -6.063 251.233 -7.969
201903 -6.275 254.202 -8.151
201906 -4.065 256.143 -5.240
201909 -4.009 256.759 -5.156
201912 -4.631 256.974 -5.951
202003 -1.379 258.115 -1.764
202006 -1.250 257.797 -1.601
202009 -0.454 260.280 -0.576
202012 -0.253 260.474 -0.321
202103 -0.416 264.877 -0.519
202106 -0.638 271.696 -0.775
202109 -0.399 274.310 -0.480
202112 -0.275 278.802 -0.326
202203 -0.345 287.504 -0.396
202206 -0.390 296.311 -0.435
202209 -0.397 296.808 -0.442
202212 -0.326 296.797 -0.363
202303 -0.077 301.836 -0.084
202306 -0.011 305.109 -0.012
202309 -0.050 307.789 -0.054
202312 -0.067 306.746 -0.072
202403 -0.090 312.332 -0.095
202406 -0.054 314.175 -0.057
202409 -0.048 315.301 -0.050
202412 0.064 315.605 0.067
202503 -0.081 319.799 -0.084
202506 -0.243 322.561 -0.249
202509 -0.068 324.800 -0.069
202512 -0.035 324.054 -0.036
202603 -0.064 330.213 -0.064

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of $-13.53 mean?
Myomo (MYO) has a Cyclically Adjusted FCF per Share of $-13.53 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Myomo and its competitors.
Is Myomo's Cyclically Adjusted FCF per Share too high?
Myomo's current Cyclically Adjusted FCF per Share is $-13.53. Overall, Myomo has a GF Score™ of 57/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Myomo's Cyclically Adjusted FCF per Share compare to FOFA and ELUT?
Myomo's Cyclically Adjusted FCF per Share of $-13.53 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted FCF per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Myomo and its competitors. Myomo's current Cyclically Adjusted FCF per Share is $-13.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Myomo stock overvalued right now?
Based on GuruFocus' analysis, Myomo (MYO) is currently considered Possible Value Trap. The stock's GF Value™ is $3.14, compared to a current price of $1.10 — trading 65% below its estimated fair value. The current Cyclically Adjusted FCF per Share is $-13.53. Myomo's overall GF Score™ is 57/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Myomo (MYO), the current Cyclically Adjusted FCF per Share is $-13.53 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Myomo (MYO) Overvalued in 2026?

Based on GuruFocus' analysis, Myomo stock appears to be undervalued. The current stock price of $1.10 is trading 65% below its estimated GF Value™ of $3.14. GuruFocus considers Myomo to be Possible Value Trap.

Key valuation signals for MYO:

  • Cyclically Adjusted FCF per Share: $-13.53
  • GF Value™: $3.14 vs. price of $1.10 (65% below fair value)
  • GF Score™: 57/100 with 6 warning signs

No single metric tells the full story. See the MYO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Myomo Business Description

Other Exchanges 0M61:Germany
Address 45 Blue Sky Drive, Suite 101, Burlington, MA, USA, 01803
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA). Geographically, it derives maximum revenue from the United States, followed by Germany, and other international.
57GF Score

Get the complete analysis for MYO

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.10
Price
$3.14
GF Value